Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Inclusion Criteria: * Aged 18-65 years of age * Who have given written informed consent after the nature of the study has been explained. * Who work within the Manchester Medical Microbiology Partnership and may be at potential occupational exposure to meningococci. Exclusion Criteria: * The possibility of pregnancy * A serious chronic disease including progressive neurological disease or seizure disorder. * Have a known bleeding diathesis, or any condition that may be associated with a prolonged bleeding time. * Have a history of severe allergic reactions after previous vaccinations such as anaphylactic shock, asthma, urticaria, or other allergic reaction or hypersensitivity to any vaccine component. * Have received another investigational agent within 90 days or before completion of the safety follow-up period in another study, whichever is longer, prior to enrollment and unwilling to refuse participation in another investigational trial through the end of the study.